Evolent Health, Inc. (EVH)

EVH Investigation 

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Evolent Health, Inc. ("Evolent" or "the Company") (NYSE: EVH). The investigation concerns whether Evolent and certain of its officers and/or directors have violated federal securities laws.

 

On May 29, 2020, Evolent issued a press release announcing, in relevant part, that “its partner, Passport Health Plan, received notification from the Kentucky Cabinet for Health and Family Services that Passport has not been awarded a Kentucky Managed Care Organization (MCO) contract for the next contract period, which commences January 1, 2021.”  Evolent further stated that it “will support Passport in protesting this decision” and “will continue to provide services to Passport until the new Medicaid contracts take effect on January 1, 2021.”  On this news, Evolent’s stock price fell $2.06 per share, or 23.2%, to close at $6.82 per share on June 1, 2020.

 

If you are aware of any facts relating to this investigation, or purchased Evolent shares, you can also contact Peretz Bronstein of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484. 

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

© 2020 Bronstein, Gewirtz & Grossman, LLC

  • Twitter Social Icon
  • LinkedIn

BG&G is not affiliated to any of these companies. All respective trademarks are owned by the respective companies.